James R. Lupski

Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (20)

While most individuals with familial medullary thyroid carcinoma (fMTC) carry RET mutations, in some instances the causative mutations remain unknown. We studied two related families with RET-negative fMTC in 21 affected individuals through linkage analysis, exome/genome sequencing, and high-density array comparative genomic hybridization. We identified a novel heterozygous 40kb intragenic SLC30A9 deletion which segregated with the disease in all affected individuals. The mutant transcript escaped nonsense-mediated decay and resulted in the production of N-terminally truncated proteins via translation reinitiation from in-frame AUG codons located downstream of the deletion. These proteins showed increased stability and their expression in an MTC cell line increased cell proliferation and clonogenic capacity, supporting an oncogenic role. These findings expand the genetic background of fMTC beyond RET mutations and implicate translation reinitiation in the etiology of cancer susceptibility syndromes secondary to structural genomic variants.

Year:

2026

Dysfunction at the centrosome-cilium interface underlies a broad range of ciliopathies. Here, we identify biallelic variants in CEP76 , encoding a centrosomal protein, in eight unrelated individuals presenting with neurodevelopmental, ocular, and variable additional multisystem features. Proband-derived fibroblasts and CEP76-depleted RPE1 cells display ciliary deficits, including impaired cilium formation and length, disrupted transition zone architecture, and impaired IFT88-mediated anterograde intraflagellar transport. Zebrafish cep76 mutants recapitulate key clinical phenotypes, and in vitro complementation assays confirm pathogenicity for all tested human disease-associated variants. Proteomics analysis identifies CEP76 interactors, including known partners CCP110 and CEP97, and highlights clinically and functionally relevant candidates, including ALMS1 and LUZP1. Together, these findings expand the role of CEP76 beyond centriole duplication to include ciliary assembly and trafficking, establishing it as a ciliopathy gene. This work provides mechanistic insights into CEP76 -related disease and broadens our understanding of centrosome-cilium biology.

Year:

2025

Year:

2025

TUBB2B encodes a β-tubulin isotype essential for neuronal proliferation, migration, and organization during brain development. Pathogenic heterozygous variants in TUBB2B have been associated with a range of neurodevelopmental disorders, with phenotypes including polymicrogyria and corpus callosum abnormalities. However, the phenotypic spectrum remains heterogeneous, likely influenced by variant-specific effects on microtubule formation and stability, an area that warrants further investigation. Homozygous TUBB2B variants are exceedingly rare, with one family reported to date. We describe five individuals in four families with rare TUBB2B variants. Four variant alleles are described, including a previously reported de novo missense variant p.(G98R), with potential phenotypic expansion including panhypopituitarism, a previously reported de novo missense variant, p.(I202T) demonstrating phenotypic heterogeneity between individuals, a de novo missense variant, p.(Q15K) at a polyamination site critical for microtubule stability, and a novel homozygous missense variant located within a region of absence of heterozygosity in two siblings from consanguineous parents p.(V49I). Both individuals also have a pathogenic homozygous truncating variant in ALKBH8 p.(R559Afs*56), representing a rare dual molecular diagnosis driving clinical features reflective of contributions from both genes. These cases expand the known clinical spectrum of TUBB2B -related tubulinopathies, illustrate intragenic phenotypic heterogeneity, including with recurrent variants and provide novel insights into potential mechanisms of disease, such as effects at polyamination sites and rare recessive inheritance, underscoring the need for nuanced genotype-phenotype interpretation in both diagnostic and counseling contexts.

Year:

2025

Poly(rC)-binding protein 1 (PCBP1), a splicing factor and key member of the hnRNP E family, was initially characterized for its tumor suppressive properties. More recently, its role in regulating gene expression in the brain and nervous system has attracted growing interest. Through an international multicenter collaboration, we identified 13 de novo pathogenic variants in PCBP1 across 13 unrelated families. All affected individuals exhibited intellectual disability (ID), with autism spectrum disorder (ASD) as a prominent feature. Functional analysis in primary hippocampal mouse neuron cultures demonstrated that PCBP1 variants impair dendritic arborization, underscoring their deleterious effects. Transcriptomic profiling by RNA sequencing of subjects-derived T cells showed a distinctive signature characterized by significantly increased exon skipping. These results highlight the essential role of PCBP1 in neurogenesis and neuritogenesis, revealing the impact of loss-of-function variants in cells harboring PCBP1 pathogenic variants, thereby confirming the link between splicing defects and neurodevelopmental disorders. Collectively, our findings demonstrate the critical role of PCBP1 in neurodevelopment, reaffirming the importance of splicing regulation in mammalian neurodevelopment.

Year:

2025

Nonsense-mediated decay (NMD) as an RNA-surveillance pathway degrades transcripts with variants introducing premature termination codons (i.e., PTC-variants), yet a substantial subset of pathogenic PTC-variants downstream of the final exon–exon junction is predicted to escape NMD (NMD-escape) based on the canonical 50-bp rule. Our systematic analysis of germline pathogenic PTC-variants from ClinVar revealed 148 autosomal dominant (AD) disease genes enriched for predicted NMD-escape alleles. These genes span nonsense (N=63), −1 frameshift (N=34), and +1 frameshift (N=22) variants, with 23 genes enriched for two classes and 6 for all three. Although their loss-of-function intolerance score distributions did not differ from controls (P = 0.407), these genes exhibited significantly higher protein–protein interaction (PPI) network centrality (P < 0.05) with their NMD-escape regions enriched for PPI interfaces (P < 0.001 for −1 and nonsense) and low-complexity sequences (P < 0.03 for −1 and +1). P/LP variants also produced significantly longer mutant C-terminal tails than controls (P < 0.01), increasing potential for functional disruption. Structural modeling of altered C-terminal tails revealed recurrent gains of glycine/proline (P < 0.03) and changes in aromatic residue content consistent with altered intrinsic disorder. Integration with neurodevelopmental disorder gene sets identified 25 dosage-sensitive genes with predicted NMD-escape P/LP variants, seven (28%) encoding condensate-forming proteins. Variant-level modeling in representative genes (e.g., KAT6B ) showed altered phase-separation propensity driven by truncated and/or altered intrinsically disordered regions. Overall, this study implicates condensate dysregulation as a potential downstream biophysical consequence of NMD-escape disease alleles, providing a protein-feature viewer for variant interpretation ( https://github.com/schmidtjacob46/NMDesc-protein-viewer ).

Year:

2025

Robinow syndrome (RS) is a genetically heterogeneous rare disorder involving six genes in the WNT/planar cell polarity (PCP) signaling pathway. Frameshifting variants in DVL genes that introduce a novel basic C-terminus are a common cause of dominant RS, accounting for ∼33% of individuals without ROR2 variants. Here, we investigated the cellular effects of pathogenic DVL frameshift variants with mutant tails of at least 82 amino acids. In silico analysis revealed altered intrinsically disordered regions (IDRs), charge distribution, and predicted structure. To explore their pathogenic mechanisms, we generated wild-type (WT), frameshift, and truncated constructs of DVL1 , DVL2 , and DVL3 , and analyzed their behavior in a transfection-based in vitro system. DVL proteins normally polymerize into cytoplasmic puncta that redistribute upon WNT stimulation. Immunocytochemistry showed that mutant DVL proteins failed to change their localization in response to WNT3A, in contrast to WT alleles—a consistent observation across all three DVLs. In line with this, TOPFlash reporter assays demonstrated that mutant DVL1 and DVL3 failed to activate canonical WNT signaling, while WT proteins induced strong activation. Additionally, the mutant C-terminal tail interfered with CSNK1E-induced phosphorylation, offering a potential mechanism underlying the impaired response. Our results provide further understanding of the cellular consequences of pathogenic DVL frameshifting variants and offers insights into the effects of such alleles on WNT signaling, and the perturbations thereof, that may lead to developmental phenotypes observed in RS.

Year:

2025

Idiopathic scoliosis (IS) is the most common form of spinal deformity with unclear pathogenesis. In this study, we firstly reanalyzed the loci associated with IS, drawing upon previous studies. Subsequently, we mapped these loci to candidate genes using either location-based or function-based strategies. To further substantiate our findings, we verified the enrichment of variants within these candidate genes across several large IS cohorts encompassing Chinese, East Asian, and European populations. Consequently, we identified variants in the EPHA4 gene as compelling candidates for IS. To confirm their pathogenicity, we generated zebrafish mutants of epha4a. Remarkably, the zebrafish epha4a mutants exhibited pronounced scoliosis during later stages of development, effectively recapitulating the IS phenotype. We observed that the epha4a mutants displayed defects in left-right coordination during locomotion, which arose from disorganized neural activation in these mutants. Our subsequent experiments indicated that the disruption of the central pattern generator (CPG) network, characterized by abnormal axon guidance of spinal cord interneurons, contributed to the disorganization observed in the mutants. Moreover, when knocked down efnb3b, the ligand for Epha4a, we observed similar CPG defects and disrupted left-right locomotion. These findings strongly suggested that ephrin B3-Epha4 signaling is vital for the proper functioning of CPGs, and defects in this pathway could lead to scoliosis in zebrafish. Furthermore, we identified two cases of IS in NGEF, a downstream molecule in the EPHA4 pathway. Collectively, our data provide compelling evidence that neural patterning impairments and disruptions in CPGs may underlie the pathogenesis of IS.

Year:

2025

Background Diagnosing rare genetic disorders relies on precise phenotypic and genotypic analysis, with the Human Phenotype Ontology (HPO) providing a standardized language for capturing clinical phenotypes. Traditional HPO tools, such as Doc2HPO and ClinPhen, employ concept recognition to automate phenotype extraction but struggle with incomplete phenotype assignment, often requiring intensive manual review. While large language models (LLMs) hold promise for more context-driven phenotype extraction, they are prone to errors and “hallucinations,” making them less reliable without further refinement. We present RAG-HPO, a Python-based tool that leverages Retrieval-Augmented Generation (RAG) to elevate LLM accuracy in HPO term assignment, bypassing the limitations of baseline models while avoiding the time and resource intensive process of fine-tuning. RAG-HPO integrates a dynamic vector database, allowing real-time retrieval and contextual matching. Methods The high-dimensional vector database utilized by RAG-HPO includes >54,000 phenotypic phrases mapped to HPO IDs, derived from the HPO database and supplemented with additional validated phrases. The RAG-HPO workflow uses an LLM to first extract phenotypic phrases that are then matched via semantic similarity to entries within a vector database before providing best term matches back to the LLM as context for final HPO term assignment. A benchmarking dataset of 120 published case reports with 1,792 manually-assigned HPO terms was developed, and the performance of RAG-HPO measured against existing published tools Doc2HPO, ClinPhen, and FastHPOCR. Results In evaluations, RAG-HPO, powered by Llama-3 70B and applied to a set of 120 case reports, achieved a mean precision of 0.84, recall of 0.78, and an F1 score of 0.80—significantly surpassing conventional tools (p<0.00001). False positive HPO term identification occurred for 15.8% (256/1,624) of terms, of which only 2.7% (7/256) represented hallucinations, and 33.6% (86/256) unrelated terms; the remainder of false positives (63.7%, 163/256) were relative terms of the target term. Conclusions RAG-HPO is a user-friendly, adaptable tool designed for secure evaluation of clinical text and outperforms standard HPO-matching tools in precision, recall, and F1. Its enhanced precision and recall represent a substantial advancement in phenotypic analysis, accelerating the identification of genetic mechanisms underlying rare diseases and driving progress in genetic research and clinical genomics.

Year:

2024

Laterality defects are defined by perturbations in the usual left-right asymmetry of organs. Due to low known genetic etiology of congenital heart disease (CHD) cases (less than 40%), we used a digenic model approach for the identification of contributing variants in known laterality defect genes (N = 115) in the exome/genome sequencing (ES/GS) data from individuals with clinically diagnosed laterality defects. The unsolved ES/GS data were analyzed from three CHD cohorts: Baylor College of Medicine-Genomics Research to Elucidate the Genetics of Rare Diseases (BCM-GREGoR; N = 247 proband ES), Gabriella Miller Kids First Pediatric Research program (Kids First; N = 158 trio GS), and Pediatric Cardiac Genomics Consortium (PCGC; N = 163 trio ES), and trans-heterozygous digenic variants were identified in 2.8% (inherited digenic variants in 0.4%), 8.2%, and 13.5% cases respectively, which was significantly higher as compared to 602 control trios provided by the 1000 Genomes Project (p = 0.001, 1.4e-07, and 8.9e-13, respectively). Trans-heterozygous digenic variants were also identified in 0.4%, and 1.4% cases with non-laterality CHD in Kids First and PCGC datasets, respectively, which was not statistically significant as compared to control trios ( p = 1, and 0.059, respectively). Altogether, in laterality cohorts, 23% of digenic pairs were in the same structural complex of motile cilia. Out of 39 unique digenic pairs in laterality CHD, 29 are more likely to be potential digenic hits as predicted by DiGePred tool. These findings provide further evidence that digenic epistatic interaction can contribute to the complex genetics of laterality defects.

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Collaborators (75)

Sharon E. Plon

Professor and Assistant Dean

Baylor College of Medicine

UNITED STATES
View details

Manolis Fanto

Lecturer/Senior Lecturer

King’s College London

UNITED KINGDOM
View details

Carol Wise

Director, Division of Molecular Genetics

Texas Scottish Rite Hospital for Children

UNITED STATES
View details

Hans Zempel

-

GERMANY
View details

Stefan Barakat

Associate professor

Erasmus MC

NETHERLANDS
View details

Anne-Francoise Roux

Université de Montpellier

FRANCE
View details

Carlo Dionisi-Vici

Head of the Division

Ospedale Pediatrico Bambino Gesù

ITALY
View details

Neil Jon Ingham

King’s College London

UNITED KINGDOM
View details

Manju A. Kurian

Professor of Neurogenetics

University College London

UNITED KINGDOM
View details

Federica Begalli

Lecturer in Endocrinology

Queen Mary University of London

UNITED KINGDOM
View details

Shaine Morris

Associate Professor

Baylor College of Medicine

UNITED STATES
View details

William Foulkes

Full Professor

McGill University

CANADA
View details

Anne Slavotinek

-

UNITED STATES
View details

Michael Duchen

Professor of Physiology

University College London

UNITED KINGDOM
View details

Richard Lewis

Professor

Baylor College of Medicine

UNITED STATES
View details

Chikashi Terao

RIKEN

JAPAN
View details

Nicolas GUEX

Head, Bioinformatics Competence Center

University of Lausanne

SWITZERLAND
View details

Marton Doleschall

senior scientist

Semmelweis University

HUNGARY
View details

Darius Ebrahimi-Fakhari

Boston Children's Hospital

UNITED STATES
View details

Lisenka Vissers

Radboud University Medical Center

NETHERLANDS
View details

Reza Maroofian

-

UNITED KINGDOM
View details

Lea Starita

Research Assistant Professor

University of Washington

UNITED STATES
View details

Horia Constantin Stanescu

University College London

UNITED KINGDOM
View details

Sissy Bassani

University of Zurich

SWITZERLAND
View details

Michael Witcher

Associate Professor

Lady Davis Institute for Medical Research

CANADA
View details

Henry Houlden

Professor of Neurogenetics

-

UNITED KINGDOM
View details

Alfredo Brusco

Full Professor in Medical Genetics

Università degli Studi di Torino

ITALY
View details

Maralyn Druce

-

UNITED KINGDOM
View details

Borut Peterlin

Head

-

SLOVENIA
View details

Jolanta Krajewska

Associate Professor

Maria Sklodowska-Curie Institute - Oncology Center Gliwice Branch

POLAND
View details

Christian Iseli

Head of Bioinformatics Competence Center

École Polytechnique Fédérale de Lausanne

SWITZERLAND
View details

Anne Barlier

Aix-Marseille University

FRANCE
View details

Florence Petit

Université de Lille

FRANCE
View details

Erica Davis

Professor

Ann and Robert H Lurie Children's Hospital of Chicago

UNITED STATES
View details

Maria Alevizaki

Professor of Endocrinology

National and Kapodistrian University of Athens

GREECE
View details

Felix Distelmaier

University Children's Hospital

GERMANY
View details

Sabrina Chiloiro

Università Cattolica del Sacro Cuore Facoltà di Medicina e Chirurgia

ITALY
View details

Stéphane Bézieau

Université de Nantes

FRANCE
View details

Márta Korbonits

Deputy Director of the William Harvey Research Institute

Queen Mary University of London

UNITED KINGDOM
View details

Donato Iacovazzo

NIHR Clinical Lecturer

Queen Mary University of London

UNITED KINGDOM
View details

Giovanna Ambrosini

Senior Scientist

EPFL (École Polytechnique Fédérale de Lausanne)

SWITZERLAND
View details

Frederic Laumonnier

Team Leader, Research Director

INSERM

FRANCE
View details

Rami Abou Jamra

University Hospital Leipzig

GERMANY
View details

Matias Wagner

Technical University of Munich

GERMANY
View details

Christian Gilissen

Professor of Genome Bioinformatics

Universitair Medisch Centrum Utrecht

NETHERLANDS
View details

Mathias Gautel

Head

King’s College London

UNITED KINGDOM
View details

Saskia Koene

Radboud Universitair Medisch Centrum

NETHERLANDS
View details

Malgorzata Oczko-Wojciechowska

Head of Department/Ph.D

Maria Sklodowska-Curie National Research Institute of Oncology

POLAND
View details

Jes Mathiesen

University of Southern Denmark

DENMARK
View details

Calvin Yip

Associate Professor

The University of British Columbia

CANADA
View details

Wendy Chung

Kennedy Family Professor

Boston Children's Hospital

UNITED STATES
View details

Rebecca Buchert

Research Group Leader

Universitätsklinikum Tübingen

GERMANY
View details

Jennifer Posey

Assistant Professor

Baylor College of Medicine

UNITED STATES
View details

Marcello Scala

Researcher

University of Genoa

ITALY
View details

R Mihai

Oxford University Hospitals NHS Foundation Trust

UNITED KINGDOM
View details

Suvi Savola

Head of Oncogenetics

MRC-Holland

NETHERLANDS
View details

Andrew Fennell

Head of Clinical Genetics

Monash Health

AUSTRALIA
View details

Pawel Gawlinski

Professor

Institute of Mother and Child

POLAND
View details

Willow Coyote-Maestas

Assistant Professor

University of California, San Francisco

UNITED STATES
View details

Carla Daniela Robles-Espinoza

Group Leader

National Autonomous University of Mexico

View details

Frédéric Ebstein

Group Leader

Université de Nantes

FRANCE
View details

Alexandre Reymond

University of Lausanne

SWITZERLAND
View details

Heinz Jungbluth

King’s College London

UNITED KINGDOM
View details

Patricia Dickson

Professor

Washington University in St. Louis

UNITED STATES
View details

Yalda Jamshidi

Director Translational Genetics

St George’s, University of London

UNITED KINGDOM
View details

Eric Venner

Baylor College of Medicine

UNITED STATES
View details

Irene Gallego Romero

Principal Research Fellow

University of Melbourne

AUSTRALIA
View details

Miklós Tóth

professor

Semmelweis University

HUNGARY
View details

Nan Wu

Assistant Professor

Baylor College of Medicine

UNITED STATES
View details

Emily M Mace

Columbia University

UNITED STATES
View details

Douglas Fowler

Professor

University of Washington

UNITED STATES
View details

Hormos Salimi Dafsari

Max Planck Institute for Biology of Ageing

GERMANY
View details

Ploski R

Medical University of Warsaw

POLAND
View details

Karen P. Steel

Professor of Sensory Function

King’s College London

UNITED KINGDOM
View details

Alan Rubin

Group Leader

University of Melbourne

AUSTRALIA
View details